NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002167

Registered date:16/07/2009

Clinical test about the monitoring of the renal function disorder at the time of the cisplatin dosage by the inulin clearance measurement

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedThe malignant tumor which needs the cisplatin dosage
Date of first enrollment2009/07/01
Target sample size50
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)inulin

Outcome(s)

Primary OutcomeCorrelation of inulin clearance and the 24 hours urine collection creatinine clearance
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum18years-old
Age maximum85years-old
GenderMale and Female
Include criteria
Exclude criteriaThe exclusion criteria are as follows; (1)The patient who uses a medicine with the antioxygenation affecting the measurement of the inulin clearance(For example, vitaminE or probucol) (2)The patient with contraindications to inulin (3)The patient with it having been administered cisplatin within the past six months (4)In addition, the patient who judged that a doctor was inappropriate

Related Information

Contact

public contact
Name
Address Japan
Telephone
E-mail yohei78525@gmail.com
Affiliation Kobe University Hospital oncology
scientific contact
Name Minami Hironobu
Address 7-5-2, Kusunoki-cho, Chuo-ku, Kobe-city, JAPAN Japan
Telephone
E-mail
Affiliation Kobe University Hospital oncology